{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:43Z","timestamp":1772165743138,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402738"],"award-info":[{"award-number":["81402738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Provincial Health Research Talents Training Programme Medical Innovation Project","award":["2019-CX-33"],"award-info":[{"award-number":["2019-CX-33"]}]},{"name":"Fujian Program for Outstanding Young Researchers in University awarded by Education Department of Fujian","award":["2017B019"],"award-info":[{"award-number":["2017B019"]}]},{"name":"the National Key Research and Development Program of China","award":["2017YFC0907100"],"award-info":[{"award-number":["2017YFC0907100"]}]},{"name":"Startup Fund of Fujian Medical University for scientific research","award":["2019QH1297"],"award-info":[{"award-number":["2019QH1297"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      This case-control study investigated the role of\n                      <jats:italic>Chlamydia pneumoniae<\/jats:italic>\n                      (Cpn) infection in the pathogenesis of lung cancer and the combined and interaction effect of Cpn infection, smoking, and various environmental factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study comprised 449 lung cancer patients and 512 age- and sex-matched healthy controls. All participants provided a 5\u2009ml fasting peripheral venous blood sample for testing Cpn-specific IgG and IgA by using micro-immunofluorescence. Besides analyzing the associations between Cpn and lung cancer, combined effect analysis, logistic regression, and the Excel table made by Andersson were used to analyze the combined and interaction effects of Cpn and environmental factors on lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to those with no evidence of serum Cpn IgA or Cpn IgG, those with both Cpn IgG+ and IgA+ had 2.00 times the risk (95% CI: 1.34\u20133.00) of developing lung cancer. Cpn IgG+ or IgA+ was associated with a significantly increased risk of lung cancer among smokers; the adjusted odds ratio (OR) was 1.79 (95% CI: 1.10\u20132.91) and 2.27 (95% CI: 1.38\u20133.72), respectively. Those exposed to passive smoking with Cpn IgG+ or IgA+ also showed an increased risk of lung cancer; the adjusted OR was 1.82 (95% CI: 1.20\u20132.77) or 1.87 (95% CI: 1.22\u20132.87), respectively. Similar results were also observed among alcohol drinkers. Multiplicative and additive interactions were not observed between Cpn infection and environmental factors. The combined effects of Cpn IgG+ or IgA+ with smoking, passive smoking, and family history of cancer on lung cancer were determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cpn infection is potentially associated with primary lung cancer in the Chinese Han population and has combined effects with smoking, passive smoking, and family history of cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07418-8","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T10:02:54Z","timestamp":1600768974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Combined and interaction effect of chlamydia pneumoniae infection and smoking on lung cancer: a case-control study in Southeast China"],"prefix":"10.1186","volume":"20","author":[{"given":"Xin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minglian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuling","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1422-6153","authenticated-orcid":false,"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"issue":"6","key":"7418_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"7418_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccm.2011.09.001","volume":"32","author":"CS Dela Cruz","year":"2011","unstructured":"Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605\u201344.","journal-title":"Clin Chest Med"},{"issue":"6","key":"7418_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C de Martel","year":"2012","unstructured":"de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607\u201315.","journal-title":"Lancet Oncol"},{"issue":"4","key":"7418_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1586\/14737140.8.4.605","volume":"8","author":"EA Engels","year":"2008","unstructured":"Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008;8(4):605\u201315.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"7418_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/aje\/kww159","volume":"185","author":"DR Brenner","year":"2017","unstructured":"Brenner DR, Fanidi A, Grankvist K, Muller DC, Brennan P, Manjer J, et al. Inflammatory cytokines and lung Cancer risk in 3 prospective studies. Am J Epidemiol. 2017;185(2):86\u201395.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"7418_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<31::AID-IJC6>3.0.CO;2-1","volume":"74","author":"AL Laurila","year":"1997","unstructured":"Laurila AL, Anttila T, L\u00e4\u00e4r\u00e4 E, Bloigu A, Virtamo J, Albanes D, et al. Serological evidence of an association between chlamydia pneumoniae infection and lung cancer. Int J Cancer. 1997;74(1):31\u20134.","journal-title":"Int J Cancer"},{"issue":"4","key":"7418_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ijc.11353","volume":"107","author":"T Anttila","year":"2003","unstructured":"Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, et al. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer. 2003;107(4):681\u20132.","journal-title":"Int J Cancer"},{"issue":"10","key":"7418_CR8","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/1055-9965.1624.13.10","volume":"13","author":"AK Chaturvedi","year":"2004","unstructured":"Chaturvedi AK, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, et al. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(10):1624\u201330.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"7418_CR9","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1158\/1055-9965.EPI-09-1261","volume":"19","author":"AK Chaturvedi","year":"2010","unstructured":"Chaturvedi AK, Gaydos CA, Agreda P, Holden JP, Chatterjee N, Goedert JJ, et al. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomark Prev. 2010;19(6):1498\u2013505.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"7418_CR10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1699-0463.1999.tb01478.x","volume":"107","author":"H Koyi","year":"1999","unstructured":"Koyi H, Brand\u00e9n E, Gnarpe J, Gnarpe H, Arnholm B, Hillerdal G. Chlamydia pneumoniae may be associated with lung cancer. Preliminary report on a seroepidemiological study. Apmis. 1999;107(9):828\u201332.","journal-title":"Apmis."},{"issue":"11","key":"7418_CR11","first-page":"1263","volume":"9","author":"LA Jackson","year":"2000","unstructured":"Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL. Association of Chlamydia pneumoniae immunoglobulin a seropositivity and risk of lung cancer. Cancer Epidemiol Biomark Prev. 2000;9(11):1263\u20136.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"7418_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1034\/j.1600-0463.2001.d01-177.x","volume":"109","author":"H Koyi","year":"2001","unstructured":"Koyi H, Brand\u00e9n E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with chlamydia pneumoniae and lung cancer. A prospective 2-year study. Apmis. 2001;109(9):572\u201380.","journal-title":"Apmis."},{"issue":"Pt 8","key":"7418_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1099\/jmm.0.04845-0","volume":"52","author":"B Kocazeybek","year":"2003","unstructured":"Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol. 2003;52(Pt 8):721\u20136.","journal-title":"J Med Microbiol"},{"issue":"3","key":"7418_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ijc.20745","volume":"114","author":"WP Koh","year":"2005","unstructured":"Koh WP, Chow VT, Phoon MC, Ramachandran N, Seow A. Lack of association between chronic Chlamydophila pneumoniae infection and lung cancer among nonsmoking Chinese women in Singapore. Int J Cancer. 2005;114(3):502\u20134.","journal-title":"Int J Cancer"},{"issue":"10","key":"7418_CR15","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/ijc.23814","volume":"123","author":"JS Smith","year":"2008","unstructured":"Smith JS, Kumlin U, Nyberg F, Fortes C, Zaridze D, Ahrens W, et al. Lack of association between serum antibodies of chlamydia pneumoniae infection and the risk of lung cancer. Int J Cancer. 2008;123(10):2469\u201371.","journal-title":"Int J Cancer"},{"issue":"3","key":"7418_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1759-7714.2010.00021.x","volume":"1","author":"Z Liu","year":"2010","unstructured":"Liu Z, Su M, Yu SC, Yin ZH, Zhou BS. Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China. Thoracic cancer. 2010;1(3):126\u20139.","journal-title":"Thoracic cancer"},{"issue":"1","key":"7418_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12885-018-4361-2","volume":"18","author":"F He","year":"2018","unstructured":"He F, Xiao RD, Lin T, Xiong WM, Xu QP, Li X, et al. Dietary patterns, BCMO1 polymorphisms, and primary lung cancer risk in a Han Chinese population: a case-control study in Southeast China. BMC Cancer. 2018;18(1):445.","journal-title":"BMC Cancer"},{"issue":"2","key":"7418_CR18","first-page":"246","volume":"33","author":"W Zhao","year":"2004","unstructured":"Zhao W, Cong L. Physical activity evaluation: metabolic equivalent intensity levels and evaluation of different physical activity. Wei Sheng Yan Jiu. 2004;33(2):246\u20139.","journal-title":"Wei Sheng Yan Jiu"},{"issue":"7","key":"7418_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","volume":"20","author":"T Andersson","year":"2005","unstructured":"Andersson T, Alfredsson L, K\u00e4llberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20(7):575\u20139.","journal-title":"Eur J Epidemiol"},{"issue":"Suppl 2","key":"7418_CR20","first-page":"e112","volume":"52","author":"X Hua-Feng","year":"2015","unstructured":"Hua-Feng X, Yue-Ming W, Hong L, Junyi D. A meta-analysis of the association between chlamydia pneumoniae infection and lung cancer risk. Indian J Cancer. 2015;52(Suppl 2):e112\u20135.","journal-title":"Indian J Cancer"},{"issue":"5","key":"7418_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ejca.2010.11.003","volume":"47","author":"P Zhan","year":"2011","unstructured":"Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, Yu LK, et al. Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer (Oxford, England : 1990). 2011;47(5):742\u20137.","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"issue":"2","key":"7418_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/039463200802100221","volume":"21","author":"R Sessa","year":"2008","unstructured":"Sessa R, Santino I, Di Pietro M, Schiavoni G, Ripa C, Galdiero M, et al. No evidence of involvement of chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reaction. Int J Immunopathol Pharmacol. 2008;21(2):415\u201320.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"7418_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148530","volume":"11","author":"S Khan","year":"2016","unstructured":"Khan S, Imran A, Khan AA, Abul Kalam M, Alshamsan A. Systems biology approaches for the prediction of possible role of chlamydia pneumoniae proteins in the etiology of lung Cancer. PLoS One. 2016;11(2):e0148530.","journal-title":"PLoS One"},{"issue":"23","key":"7418_CR24","first-page":"7415","volume":"50","author":"S Preston-Martin","year":"1990","unstructured":"Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res. 1990;50(23):7415\u201321.","journal-title":"Cancer Res"},{"issue":"4","key":"7418_CR25","first-page":"185","volume":"17","author":"A Rizzo","year":"2014","unstructured":"Rizzo A, Carratelli CR, De Filippis A, Bevilacqua N, Tufano MA, Buommino E. Transforming activities of chlamydia pneumoniae in human mesothelial cells. Int Microbiol. 2014;17(4):185\u201393.","journal-title":"Int Microbiol"},{"issue":"6","key":"7418_CR26","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.7314\/APJCP.2012.13.6.2819","volume":"13","author":"DJ Chu","year":"2012","unstructured":"Chu DJ, Guo SG, Pan CF, Wang J, Du Y, Lu XF, et al. An experimental model for induction of lung cancer in rats by chlamydia pneumoniae. Asian Pacific J Cancer Prev. 2012;13(6):2819\u201322.","journal-title":"Asian Pacific J Cancer Prev"},{"issue":"3","key":"7418_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/tobaccocontrol-2011-050301","volume":"22","author":"BJ Apelberg","year":"2013","unstructured":"Apelberg BJ, Hepp LM, Avila-Tang E, Gundel L, Hammond SK, Hovell MF, et al. Environmental monitoring of secondhand smoke exposure. Tob Control. 2013;22(3):147\u201355.","journal-title":"Tob Control"},{"issue":"7","key":"7418_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0278-6915(00)00051-X","volume":"38","author":"CJ Smith","year":"2000","unstructured":"Smith CJ, Hansch C. The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol. 2000;38(7):637\u201346.","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"7418_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/carcin\/bgh103","volume":"25","author":"LI Proulx","year":"2004","unstructured":"Proulx LI, Castonguay A, Bissonnette EY. Cytokine production by alveolar macrophages is down regulated by the alpha-methylhydroxylation pathway of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis. 2004;25(6):997\u20131003.","journal-title":"Carcinogenesis."},{"issue":"10","key":"7418_CR30","first-page":"1212","volume":"42","author":"T Li","year":"2017","unstructured":"Li T, He X, Chen Y. Mechanism of lung cancer and chronic obstructive pulmonary disease. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017;42(10):1212\u20136.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"8","key":"7418_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1513\/pats.200809-100TH","volume":"5","author":"T Walser","year":"2008","unstructured":"Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, et al. Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc. 2008;5(8):811\u20135.","journal-title":"Proc Am Thorac Soc"},{"issue":"10","key":"7418_CR32","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.rmr.2018.02.009","volume":"35","author":"P Arvers","year":"2018","unstructured":"Arvers P. Alcohol consumption and lung damage: dangerous relationships. Rev Mal Respir. 2018;35(10):1039\u201349.","journal-title":"Rev Mal Respir"},{"issue":"2","key":"7418_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.lungcan.2013.05.004","volume":"81","author":"Y He","year":"2013","unstructured":"He Y, Li S, Ren S, Cai W, Li X, Zhao C, et al. Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patients. Lung Cancer. 2013;81(2):162\u20136.","journal-title":"Lung Cancer"},{"issue":"3","key":"7418_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1128\/CDLI.11.3.615-617.2004","volume":"11","author":"AJ Littman","year":"2004","unstructured":"Littman AJ, Jackson LA, White E, Thornquist MD, Gaydos CA, Vaughan TL. Interlaboratory reliability of microimmunofluorescence test for measurement of chlamydia pneumoniae-specific immunoglobulin a and G antibody titers. Clin Diagn Lab Immunol. 2004;11(3):615\u20137.","journal-title":"Clin Diagn Lab Immunol"},{"key":"7418_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0065-2776(08)60240-0","volume":"40","author":"J Mestecky","year":"1987","unstructured":"Mestecky J, McGhee JR. Immunoglobulin a (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol. 1987;40:153\u2013245.","journal-title":"Adv Immunol"},{"issue":"4","key":"7418_CR36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1128\/CDLI.2.4.454-457.1995","volume":"2","author":"L von Hertzen","year":"1995","unstructured":"von Hertzen L, Leinonen M, Surcel HM, Karjalainen J, Saikku P. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with chlamydia pneumoniae. Clin Diagn Lab Immunol. 1995;2(4):454\u20137.","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07418-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T09:15:18Z","timestamp":1668849318000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07418-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7418"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07418-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23930\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23930\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"11 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of Fujian Medical University (Fuzhou, China). All participants signed informed consent forms.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no financial or non-financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"903"}}